Go Pro
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Price, News & Analysis

Merck KGaA logo
$160.71 0.00 (0.00%)
As of 07/13/2026 03:53 PM Eastern

About Merck KGaA Stock (OTCMKTS:MKGAF)

Advanced

Key Stats

Today's Range
$154.11
$165.39
50-Day Range
$131.64
$174.77
52-Week Range
$116.68
$175.56
Volume
296 shs
Average Volume
615 shs
Market Capitalization
$20.77 billion
P/E Ratio
24.54
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merck KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

MKGAF MarketRank™: 

Merck KGaA scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Merck KGaA.

  • Earnings Growth

    Earnings for Merck KGaA are expected to grow by 8.21% in the coming year, from $9.75 to $10.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Merck KGaA is 24.54, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.16.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Merck KGaA is 24.54, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.11.

  • Price to Book Value per Share Ratio

    Merck KGaA has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Merck KGaA's valuation and earnings.
  • Percentage of Shares Shorted

    0.53% of the float of Merck KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Merck KGaA has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Merck KGaA has recently decreased by 22.98%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Merck KGaA does not currently pay a dividend.

  • Dividend Growth

    Merck KGaA does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Merck KGaA this week, compared to 1 article on an average week.
Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MKGAF Stock News Headlines

Merck KGaA (OTCMKTS:MKGAF) Sets New 52-Week High - Here's Why
Under $1 while the market panics
The new deadline for crypto’s best bill, the Clarity Act, is August 7th. That's the Senate's final session day before summer recess. The bill needs 60 votes, seven Democrats crossing the aisle. If it happens, trillions in institutional capital finally gets the legal rulebook it's been waiting years for. And our analysts have identified one specific altcoin they believe was built for exactly this moment. Not for retail hype… for the kind of regulated, institutional finance the CLARITY Act unlocks.tc pixel
See More Headlines

MKGAF Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $147.60 on January 1st, 2026. Since then, MKGAF stock has increased by 8.9% and is now trading at $160.71.

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/14/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
62,908
Year Founded
1891

Profitability

EPS (Trailing Twelve Months)
$6.81
Trailing P/E Ratio
24.54
Forward P/E Ratio
16.48
P/E Growth
N/A
Net Income
$3.06 billion
Net Margins
12.60%
Pretax Margin
15.64%
Return on Equity
10.17%
Return on Assets
5.74%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.31
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$22.72 billion
Price / Sales
0.91
Cash Flow
$48.41 per share
Price / Cash Flow
3.32
Book Value
$212.00 per share
Price / Book
0.76

Miscellaneous

Outstanding Shares
129,240,000
Free Float
N/A
Market Cap
$20.77 billion
Optionable
Not Optionable
Beta
0.96

Social Links

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:MKGAF) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners